BlackRock’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,358,886
| Closed | -$857K | – | 5576 |
|
|
2023
Q1 | $857K | Sell |
3,358,886
-98,253
| -3% | -$25.1K | ﹤0.01% | 4295 |
|
|
2022
Q4 | $4.08M | Buy |
3,457,139
+442,249
| +15% | +$522K | ﹤0.01% | 3749 |
|
|
2022
Q3 | $6.15M | Buy |
3,014,890
+2,586,124
| +603% | +$5.28M | ﹤0.01% | 3594 |
|
|
2022
Q2 | $660K | Buy |
428,766
+12,488
| +3% | +$19.2K | ﹤0.01% | 4590 |
|
|
2022
Q1 | $2.1M | Buy |
+416,278
| New | +$2.1M | ﹤0.01% | 4283 |
|